Atopic Dermatitis Perspective

 
 
  • AAD 2025 Atopic Dermatitis Highlights From AAD 2025   Atopic dermatitis highlights from AAD 2025 include phase 3 trial results on rocatinlimab and delgocitinib, findings on tapinarof 1% cream, and early dosing data on a new JAK1/TYK2 inhibitor.
  • AAAAI 2025 Urticaria, Angioedema, and Anaphylaxis Highlights From AAAAI   The changing therapeutic landscape for urticaria, angioedema, and anaphylaxis is evidenced by emerging treatments reported at AAAAI and discussed by Dr Ruchi Gupta.
  • From Eczema to Rare Lymphoma: Delayed Diagnosis in a Child Despite multiple treatments for eczema and pityriasis alba, a child’s skin condition worsened until a biopsy revealed mycosis fungoides.
  • The Essence of Essential Oils Essential oils are known to impart antioxidant, anti-inflammatory, antimicrobial, and other functions beneficial to health and are useful in various medications and other products developed to treat the skin.
  • AAD 2025 Read clinically focused news coverage of key developments from AAD 2025
  • Microplastics in Personal Care Products: Out! Dermatologists warn that microplastics intentionally added to personal care products are not ‘just’ harming the environment.
  • Ricinus communis (Castor) Seed Oil Castor oil is among several oils that have been used traditionally by people of color, particularly those with Indian or African heritage, to treat hair and scalp conditions.
  • MauiDerm 2025 Read clinically focused news coverage of key developments from MauiDerm 2025
  • Sea Buckthorn Sea buckthorn berries, seeds, and leaves have been used in traditional medicine to treat burns/injuries, edema, hypertension, inflammation, skin grafts, ulcers, and wounds.
  • More Than Hives: Discussing Chronic Spontaneous Urticaria   Dermatologists discuss common roadblocks in communicating with patients with chronic spontaneous urticaria, who often search for a cause they can fix for a condition lacking in community resources.
  • ACAAI 2024: Impact of New Food Allergy Recommendations   Dr Ruchi Gupta offers insights on the clinical implications of updated food allergy prevention guidelines and new treatments, including oral immunotherapy and biologics.
  • Conference MDAngle: ACAAI 2024 Food Allergy & GI Disorders Dr Ruchi Gupta shares ACAAI 2024 highlights, including anticipated presentations, quick takeaways, and insights into how new research will affect her patients.
  • ACAAI 2024: Anticipating Updates in Food Allergies and GI Disorders   Dr Ruchi Gupta previews updates on food allergy treatments and GI disorders, including new biologics and advancements in eosinophilic esophagitis and FPIES.
  • SPD 2024 Read clinically focused news coverage of key developments from SPD 2024.
  • Fostering Effective Communication With Food Allergy Patients   In this Care Cues, a physician and a young adult with food allergies share strategies on fostering effective communication about allergy management, from childhood to independent health management.
  • AAD 2024 Read clinically focused news coverage of key developments AAD 2024
  • Topical Treatment for Atopic Dermatitis Professor Peter A. Lio reviews atopic dermatitis topical therapies for Medscape.
  • Keeping It Simple: Treatment Choices for Atopic Dermatitis   Experts discuss effective nonsteroidal and alternative topicals for mild atopic dermatitis and the expanding range of systemic therapies, including JAK inhibitors, for patients with severe AD.
  • ACAAI 2023 Read clinically focused news coverage of key developments from ACAAI 2023.
  • Atopic Dermatitis: 5 Things to Know From subtle differences in presentation to diagnostic pearls and the newest and emerging treatments, check out these 5 things to know about atopic dermatitis.